In most cases, the complications are due to ischemic optic neuropathy. In a cohort of 161 Spanish patients with biopsy-proven GCA, 26% experienced visual symptoms.

Prognosis & Outcome In one study of 161 patients with biopsy-proven GCA followed up for 11 years, the prevalence of visual ischemic complications was 26.1% and the prevalence of irreversible ...

NAION risk is most significant within the first 12 months of beginning semaglutide, and is highest in patients with additional risk factors.

Background: Giant cell arteritis (GCA) is a granulomatous vasculitis in older individuals that primarily affects medium-to-large vessels. Owing to the involvement of the ophthalmic arteries, GCA can ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

Upadacitinib 15 mg — but not 7.5 mg — alongside a glucocorticoid taper demonstrated superior efficacy to placebo with a ...

Cosentyx missed its main goal in a Phase 3 GCA study, but showed lower steroid use. Novartis plans full review of the trial ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant ...

“While the phase 3 results of GCAptAIN did not replicate the positive outcomes observed in the phase 2 trial, we remain committed to continuing to drive scientific progress and deepening the ...

Novartis (NYSE:NVS) (OTCPK:NVSEF) announced Thursday that its FDA-approved anti-inflammatory agent Cosentyx failed to reach ...

In the 2004 Bowman Lecture, I give a panegyric for Sir William Bowman, an estimate of the importance and the epidemiology of anterior visual pathway developmental disorders, followed by a history ...

Novartis NVS announced that a late-stage study of its interleukin-17A inhibitor, Cosentyx (secukinumab), has failed to meet ...